[ CSE: OPTI ] [ OTCQX: OPTHF ] [FSE: 8BN ]

Leading the Way in Psychedelic-based Mental Health Treatments

Optimi Health

Optimi Health Corp. is an end-to-end Canadian-based drug manufacturer and formulator licensed by Health Canada to produce and supply psychedelic substances such as 3,4 Methylenedioxy methamphetamine (“MDMA”) and natural GMP-grade psilocybin, as well as functional mushrooms that focus on the health and wellness markets

The use of psychedelics as a revolutionary treatment for depression and other mental health disorders is gaining significant traction globally. Optimi Health is positioned to deliver cost-effective, GMP-certified MDMA & Psilocybin under Health Canada’s Drug Establishment License to regulated markets around the world

Optimi’s products are grown and manufactured at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia

Company Highlights

Two Psychedelic Drugs Available in a Prescription Market
Strong Financial Support and Backing From Insiders & Founders
Cost-Effective On-Site GMP Manufacturing and Production
Access to Real World Data & Patient Outcomes using Optimi's Products
Licensed & Ready to Export MDMA & Psilocybin Capsules Globally
Ability to Participate in Future Regulated Markets Imminently

For business inquiries please contact:
sales@optimihealth.ca

For media inquiries please contact:
pr@optimihealth.ca

For investor inquiries please contact:
investors@optimihealth.ca

Products do not contain psilocybin

Search
Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.